Boston Partners’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
Boston Partners's HOLX Position: Q1 2025 in Review
Boston Partners sold out of Hologic (HOLX) in Q1 2025, closing a stake of 3,580,519 shares — an estimated $258M sold.
Boston Partners first reported a position in HOLX in Q2 2013 and held it in 19 quarters. The position peaked at $258M in Q4 2024. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.
- Boston Partners reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
- Boston Partners sold 3,580,519 Hologic shares in Q1 2025, an estimated $258M.
- Boston Partners first reported a position in Hologic in Q2 2013 and held it in 19 quarters.
- Boston Partners's Hologic position peaked at $258M in Q4 2024.
- 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.